| Microorganism |
MIC50
(μg/ml) |
MIC90
(μg/ml) |
Range
(μg/ml) |
Antimicrobial |
Reference |
| Staphylococcus aureus (KVR-Y) |
- |
- |
0.0625 － ? |
Teicoplanin (Targocid)  |
670 |
| Staphylococcus aureus (KVR-Y) |
- |
- |
0.125 － ? |
Imipenem |
670 |
| Staphylococcus aureus (KVR-Y) |
- |
- |
0.125 － ? |
Levofloxacin (Levaquin, Quixin) |
670 |
| Staphylococcus aureus (KVR-Y) |
- |
- |
0.25 － ? |
Ceftizoxime (Cefizox) |
670 |
| Staphylococcus aureus (KVR-Y) |
- |
- |
0.25 － ? |
Vancomycin (Vancocyn, Lyphocin) |
670 |
| Staphylococcus aureus (KVR-Y) |
- |
- |
1 － ? |
Oxacillin (Prostaphilin, Bactocil, Prostaphlin) |
670 |
| Staphylococcus aureus (KVR-Y) |
- |
- |
2 － ? |
Bacitracin (Baci-IM) |
670 |
| Staphylococcus aureus (KVR-Y) |
- |
- |
2 － ? |
Fosfomycin (Phosphonomycin, Phosphomycin, Monurol) |
670 |
| Staphylococcus aureus (KVR-Y) |
- |
- |
16 － ? |
Cefalexin (Keflex) |
670 |
| Staphylococcus aureus (KVR-Y) |
- |
- |
32 － ? |
D-cycloserine |
670 |
| Staphylococcus aureus (L form) |
- |
- |
16 － ? |
Nisin |
801 |
| Staphylococcus aureus (L form) |
- |
- |
64 － ? |
Mersacidin |
801 |
| Staphylococcus aureus (L form) |
- |
- |
>128 － ? |
Actagardine |
801 |
| Staphylococcus aureus (L form) |
- |
- |
>128 － ? |
Microbisporicin |
801 |
| Staphylococcus aureus (L form) |
- |
- |
>128 － ? |
Planosporicin |
801 |
| Staphylococcus aureus (L15009/pI258 + penicillin-resistant) |
- |
- |
0.05 － ? |
Faropenem |
40 |
| Staphylococcus aureus (lab strain) |
- |
- |
100 － ? |
Holarrhena pubescens bark (Alkaloids) |
384 |
| Staphylococcus aureus (levofloxacin-intermediate) |
- |
- |
2 － ? |
Levofloxacin (Levaquin, Quixin) |
452 |
| Staphylococcus aureus (levofloxacin-resistant) |
- |
- |
≥4 － ? |
Levofloxacin (Levaquin, Quixin) |
452 |
| Staphylococcus aureus (levofloxacin-susceptible) |
- |
- |
≤1 － ? |
Levofloxacin (Levaquin, Quixin) |
452 |
| Staphylococcus aureus (linezolid-resistant + methicillin-resistant) |
- |
- |
1 － 2 |
Vancomycin (Vancocyn, Lyphocin) |
189 |
| Staphylococcus aureus (linezolid-resistant + methicillin-resistant) |
- |
- |
4 － 16 |
RWJ-416457 |
189 |
| Staphylococcus aureus (linezolid-resistant + methicillin-resistant) |
- |
- |
8 － >32 |
Linezolid (PNU-100766, U-100766, Zyvox) |
189 |
| Staphylococcus aureus (linezolid-resistant + methicillin-resistant) |
- |
- |
>32 － ? |
Oxacillin (Prostaphilin, Bactocil, Prostaphlin) |
189 |
| Staphylococcus aureus (linezolid-resistant) |
0.25 |
2 |
0.12 － 8 |
TR-700 |
192 |
| Staphylococcus aureus (linezolid-resistant) |
1 |
2 |
≤0.12 － 4 |
Daptomycin (Cubicin) |
483 |
| Staphylococcus aureus (linezolid-resistant) |
2 |
16 |
1 － 64 |
Linezolid (PNU-100766, U-100766, Zyvox) |
192 |
| Staphylococcus aureus (linezolid-resistant) |
- |
- |
0.03 － 0.06 |
Dalbavancin |
1112 |